Brilitas Pharmaceuticals EU OÜ
Brilitas Pharmaceuticals EU OÜ is a OÜ based in Tallinn, registry code 16618699, status: active. Main activity: All other professional, scientific and technical activities n.e.c.. According to EMTA, turnover for Q3 2026 was €0 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2025 750 €above 28% of companiesindustry median 6 586 € · companies in the industry: 7 527
Taxes and turnover
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | — | — | — |
| Q2 2026 | — | — | — | — |
| Q1 2026 | — | — | — | — |
| Q4 2025 | — | 1 974 | — | — |
| Q3 2025 | — | — | — | — |
| Q2 2025 | — | — | — | — |
| Q1 2025 | — | 121 | 121 | — |
| Q4 2024 | — | 330 | 330 | — |
| Q3 2024 | — | 395 | 399 | — |
| Q2 2024 | — | — | — | 1 |
| Q1 2024 | — | — | — | — |
Financials by year
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 750 | -15 891 | 0 | 59 422 | 59 422 | 0 |
| 2024 | 24 000 | 15 854 | 725 | 34 339 | 34 339 | 1 |
| 2023 | 0 | -1 451 | 0 | 114 | -1 451 | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 18 Nov 2025 | Company’s own | e-Äriregister |
| 2023 | 22 Nov 2022 – 31 Dec 2023 | 17 May 2024 | Company’s own | e-Äriregister |
Board
- Quang Dăng TranBoard member · since 22 Nov 2022
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Quang Dăng TranNatural person · 65 000 €
Beneficial owners
- Quang Dăng TranDirect ownership · since 22 Nov 2022
Founders and other persons
- Quang Dăng TranFounder · 2 500 € · 22 Nov 2022
Activities (EMTAK)
- 74991All other professional, scientific and technical activities n.e.c. Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50215655 / M2 5 Nov 2025 |
Ruling to eliminate deficiencies in the annual report | 19 Nov 2025 | Deficiencies eliminated 18 Nov 2025 |
|
| Ä 50215655 / 5 14 Oct 2024 |
Amendment entry | In force 14 Oct 2024 |
||
| Ä 50215655 / 4 24 May 2024 |
Amendment entry | In force 24 May 2024 |
||
| Ä 50215655 / M1 23 May 2024 |
Ruling to eliminate deficiencies | 22 Jun 2024 | Deficiencies eliminated 20 May 2024 |
|
| Ä 50215655 / 3 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50215655 / 2 1 Feb 2023 |
Amendment entry | In force 1 Feb 2023 |
||
| Ä 50215655 22 Nov 2022 |
First entry | In force 22 Nov 2022 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data